SABCS 2023: Defining and Demystifying Inflammatory Breast Cancer
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of...
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...
Researchers, physicians, patients, and other stakeholders convened in San Antonio, Texas, December 6-10 for the annual San Antonio Breast...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...